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ABSTRACT 
The ligand specificity and biochemical properties of the human (h) 
FSH receptor are poorly characterized due to the low abundance of 
these receptors and the limited availability of human tissues. Using a 
fragment of rat FSH receptor cDNA, we screened a human testicular 
cDNA librarv and obtained a FSH receotor cDNA covering the entire 
amino acid-coding region. After transfection of a human fetal kidney 
cell line (293) with the hFSH receptor cDNA, radioligand receptor 
analysis revealed the presence of high affinity (Kd, 1.7 x 10m9 M) FSH- 
binding sites on the plasma membrane. Both recombinant and wild- 
type hFSH displaced [““I]hFSH binding, with EDso values of 25 and 
70 nr/ml. resnectivelv. whereas hLH. hCG. and hTSH were ineffective. 
Although human, rat”(r), and ovine FSH as well as equine CG competed 
for rat testicular FSH receptor binding, only hFSH and rFSH inter- 
acted effectively with the recombinant hFSH receptor, suggesting that 
species-specific ligand recognition exists between human and rodent 
receptors. After incubation of transfected cells with hFSH, but not 
recombinant hLH or hCG, a dose-dependent increase (EDso, 10 rig/ml) 
in extracellular CAMP accumulation was observed, indicating a func- 
tional coupling of the expressed human receptor with the endogenous 
adenyl cyclase. In cells cotransfected with the FSH receptor expression 
plasmid and a luciferase reporter gene driven by the promoter of a 
CAMP-responsive gene, treatment with hFSH, but not hCG, resulted 
in a dose-dependent increase in luciferase activity. Northern blot 
analysis using a cRNA probe derived from the human receptor cDNA 
indicated the presence bf multiple FSH receptor mRNA transcripts 
(7.0, 4.2, and 2.5 kilobases) in RNA prepared from human follicular 
phase ovary, but not from human corpus luteum or placenta. Addition- 
ally, two FSH-binding sites of 76 and 112 kilodaltons were detected in 
transfected 293 cells-after ligand/receptor cross-linking and sodium 
dodecyl sulfate-polyacrylamide gel electorphoresis analysis. These re- 
sults demonstrate the expression of functional hFSH receptor with 
unique ligand specificity and provide new data on the biochemical 
properties of the human receptor at the mRNA and protein levels. 
(Endocrinology 131: 799~806,1992) 
F SH IS a member of the glycoprotein hormone family that also comprises LH, CG, and TSH (1, 2). Hormones of 
this family are dimers consisting of a common oc-subunit and 
hormone-specific @.ubunits joined together by noncovalent 
binding (3). As with the other glycoprotein hormones, FSH 
binding to target cells increases adenyl cyclase activity 
through interaction with membrane-associated G-proteins 
(4), thus classifying the FSH receptor to the G-protein- 
coupled receptor family (5-7). The hallmark of G-protein- 
coupled receptors is the presence of seven transmembrane- 
spanning segments that possess a homologous cluster of six 
or seven amino acid residues located on the carboxyl-termi- 
nal region of the third cytoplasmic loop. Recent molecular 
cloning of rat LH and FSH receptors have indicated that this 
conserved region, which has been implicated in G-protein 
coupling of the fl-adrenergic receptor (8-10) and TSH recep- 
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tor (ll), is also present in the third cytoplasmic loop of 
gonadotropin receptors (12, 13). 
Although the importance of FSH in testicular and ovarian 
development and reproductive function has been unequiv- 
ocally established (for review, see Refs. 14-16), the limited 
availability of human gonadal tissues as well as the paucity 
of gonadal FSH-binding sites have precluded the study of 
human (h) FSH receptors. Recent studies from our laboratory 
have indicated that the ligand specificity of human US. rat (r) 
LH receptors is dramatically different, suggesting that the 
properties of human gonadotropin receptors may differ from 
those of experimental animal models (17). To more clearly 
elucidate the properties of hFSH receptors, we report here 
the expression of a functional recombinant hFSH receptor 
with unique ligand specificity. Furthermore, the distribution 
of FSH receptor mRNA in human reproductive tissues and 
the biochemical properties of the expressed receptor are 
presented. 
Materials and Methods 
Reagents and hormones 
Restriction enzymes were obtained from Bethesda Research Labora- 
tories (BRL; Gaithersburg, MD), Boehringer-Mannheim (Indianapo- 
lis, IN), and Stratagene (La Jolla, CA). A hgtll human testicular cDNA 
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library was obtained from Clontech (Palo Alto, CA). The eukaryotic 
expression vector pCMX was a gift from Dr. K. Umesono of The Salk 
Institute (San Diego, CA). The recombinant human gonadotropin prep- 
arations were derived from serum-free conditioned medium of Chinese 
hamster ovary (CHO) cell lines transfected with human gonadotropin 
genes. The recombinant hLH contains a deletion of seven hydrophobic 
amino acids at the carboxyl-terminus and a substitution of Trp to Arg at 
position eight of the P-subunit for efficient dimerization and secretion 
from CHO cells (18). The recombinant hFSH has biological activity and 
chromatofocusing profiles similar to those of purified pituitary FSH (19). 
The concentrations of the recombinant gonadotropins were estimated in 
RIAs using purified pituitary preparations as standards (hLH, hLH I-3, 
5,900 lU/mg; hFSH, hFSH I-3, 3,100 IU/mg by the hCG augmentation 
assay). hFSH (I-3), hCG (CR-127; 14,900 IU/mg), hLH (Bl; 4,015 IU/ 
mg), hTSH (Bl; 15 IU/mg), rFSH (I-7; 4,714 IU/mg), and ovine (0) FSH 
(oFSH-17; 25 IU/mg) were obtained from the National Hormone and 
Pituitary Distribution Program (Bethesda, MD); recombinant hTSH was 
obtained from Genzyme (Cambridge, MA); equine (e) CG (PMSG; 2,530 
IU/mg) was obtained from Calbiochem (La Jolla, CA); and porcine (p) 
FSH was the gift of Dr. H. Papkoff (University of California-San 
Francisco). Reagents required for the luciferase assay were purchased 
from Analytical Luminescence Laboratory (San Diego, CA). 
cDNA library screening 
A fragment of rFSH receptor cDNA, corresponding to bases 621- 
1031 of the published sequence (13), was obtained by reverse transcrip- 
tion-polymerase chain reaction of RNA prepared from PMSG-primed 
rat ovaries (20). This cDNA fragment was radiolabeled by the random 
priming method (21) and used to screen the human testicular cDNA 
library (22). Eight positively hybridizing phage clones ranging in size 
from 1.8-2.2 kilobases (kb) were isolated, subcloned into the pBluescript 
II SK plasmid (Stratagene), and sequenced using the dideoxy chain 
termination method (23) with a DNA sequencing kit (U.S. Biochemical 
Corp., Cleveland, OH) and specific primers. Individual fragments ob- 
tained from two separate clones (H37 and G3) were prepared by BamHI 
restriction enzyme digestion and ligated at nucleotide position 686 to 
yield the final hFSH receptor cDNA construct containing the entire 
amino acid-coding region. Clone H37 contains 75-basepairs (bp) of 5’. 
untranslated region plus 1562 bp of open reading frame, but lacks the 
3’.end and polyadenylation signal. Clone G3 starts at 168 bp of the 
open reading frame and covers the entire amino acid-coding region to 
the termination codon plus 26 bp of the 3’.untranslated region. These 
clones contain a 1394.bp overlapping region with identical nucleotide 
sequence, the identity of which was further confirmed by sequence 
analysis of the remaining six clones. The DNA sequence of the final 
clone was determined on both strands and compared to the published 
sequence of a cloned, but not expressed, human ovarian FSH receptor 
cDNA (24). Sequence comparison indicated seven individual basepair 
substitutions between our and the reported clone, resulting in five 
different amino acids at the following positions: 112 (Thr to Asn), 197 
(Ala to Glu), 198 (Val to Leu), 307 (Ala to Thr), and 680 (Ser to Asn). 
Expression of full-length cDNA in eukaryotic cells 
An EcoRI linker @omega, Madison, WI) was inserted into the EcoRV 
restriction site of the pCMX expression vector (17) to generate a plasmid 
(designated pCME) containing an EcoRI cloning site. The cDNA construct 
coding for the entire hFSH receptor (-75 to 2085 bp plus 26 bp of the 
3’.untranslated region) was then subcloned into the EcoRI site of the 
&ME vector and partially sequenced to determine the orientation of 
the cDNA insert. Exponentially growing 293 cells derived from human 
fetal kidney were transiently transfected in 5 ml Dulbecco’s Modified 
Eagle’s Medium (DMEM; supplemented with 5% fetal calf serum, 2 rnM 
L-glutamine, 100 U/m1 penicillin, and 100 pg/mI streptomycin sulfate; 
Gibco, Santa Clara, CA) with the expression plasmid (designated pCME- 
hFSHR) using the calcium phosphate precipitation method (25) used 
routinely in our laboratory (17). Twenty-four hours after transfection, 
FSH receptor binding studies were performed by incubating cells (2 X 
10”/0.4 ml) with [‘251]hFSH at 22 C for 20 h or as indicated. Iodination 
of hFSH (I-3) was performed using the lactoperoxidase method (26). 
The specific activity and maxima1 binding of [‘?]hFSH, as determined 
by radioligand receptor assay using rat testicular membranes, were 
99,000-110,000 cpm/ng and 7%, respectively. Nonspecific binding was 
determined by inclusion of a 1,000.fold excess of unlabeled ligand 
(Pergonal, Serono Laboratories, Randolph, MA). Similar procedures 
were used to analyze the ligand specificity of FSH-binding sites in 
testicular homogenates prepared from 15-day-old Sprague-Dawley rats 
(Johnson Labs, Bridgeview, IL). For CAMP analysis, transfected 293 cells 
(2 X 105/culture dish) were treated with various gonadotropins in the 
presence of 0.25 mM 3-isobutyl-l-methylxanthine (MIX; Sigma Chemical 
Co., St. Louis, MO) for 2 h at 37 C. After incubation, extracellular CAMP 
levels were determined by specific RIA, using [‘*sI]cAMP (ICN, Costa 
Mesa, CA) as the labeled ligand and a commercially available CAMP 
antiserum (ICN) (27). The intra- and interassay coefficients of variation 
were 6% and lo%, respectively. 
Luciferase reporter gene 
A 654-bp fragment of the 5’.flanking sequence of the rat tissue 
plasminogen activator (PA) gene ligated to the luciferase gene plasmid 
pl9LUC (28) was used (designated ptPA-LUC) (29). This portion of the 
tPA promoter region contains a CAMP-responsive element capable of 
mediating gonadotropin-stimulated tPA gene transcription (29). Expo- 
nentially growing 293 cells were transiently transfected in 5 ml DMEM 
with pCME-hFSHR and ptPA-LUC plasmids (at a ratio of 0.8:0.2; 7.5 
pg total DNA). After transfection, cells were collected, counted, and 
dispensed into 12 X 75-mm culture tubes (5 X IO4 cells/tube). The total 
volume was brought to 0.3 ml with DMEM containing 0.25 mM MIX 
with hFSH or hCG, and cells were incubated for 18 h at 37 C. After 
incubation, cells were Iysed by the addition of 0.3 ml/tube 2 X lysis 
buffer [50 mM Tris-phosphate (pH 7.8), 4 mM dithiothrietol, 4 mM 1,2- 
diaminocyclohexane-N,N,N’,N’-tetraacetic acid, 20% glycerol, and 2% 
Triton X-100] at 22 C for 15 min. For estimation of luciferase activity, 
10 ~1 cell lysate mixture were combined with 100 ~1 assay reagent [20 
mM tricine, 1.07 mM (MgCO& Mg(OH)Z-5H20, 2.67 mM MgSO,, 0.1 
mM EDTA, 33.3 mM dithiothrietol, 270 PM coenzyme-A, 470 HM luciferin, 
and 530 PM ATP], and light production was immediately measured for 
10 set in a luminometer (Monolight 2010, Analytical Luminescence 
Laboratory). 
Preparation of nucleic acid probe for hFSH receptor mRNA 
A fragment of the hFSH receptor cDNA, corresponding to bases 744- 
1026, was isolated after digestion of the hFSH receptor cDNA with the 
HirzcII restriction enzyme. This fragment, which possesses less than 50% 
nucleotide sequence homology to the hLH receptor cDNA (17), was 
subcloned into the pGEM4z vector (Promega). The plasmid clone was 
linearized with the Sal1 restriction enzyme and served as a template for 
the production of a cRNA probe using T7 RNA polymerase (BRL) and 
[a-32P]CTP (3000 Ci/mmol; Amersham, Arlington Heights, IL), as pre- 
viously described (30). 
Northern blot analysis 
Human ovarian and placental tissues were provided by Dr. T. Tanaka 
(Hokkaido University, Sapporo, Japan) and Dr. A. Murphy (University 
of California-San Diego), respectively. Total RNA was extracted from 
human tissues using the guanidinium thiocyanate-phenol-chloroform 
extraction procedure (31). Total RNA samples were enriched for poly(A) 
mRNA by a single round of oIigo(dT) column chromatography (Phar- 
macia LKB Biotechnology, Piscataway, NJ) and electrophoresed through 
1% agarose-2.2 M formaldehyde gels. Samples were blotted onto nitro- 
cellulose membranes (Schleicher and Schuell, Keene, NH) by overnight 
capillary electrophoresis and covalently cross-linked using a UV cross- 
linker (Stratagene). Membranes were then prehybridized for 2-4 h at 65 
C in the presence of 50% formamide under standard conditions, fol- 
lowed by hybridization with the radiolabeled hFSH receptor cRNA 
probe at the same temperature for 18-20 h (20, 32, 33). Membranes 
were washed in 2 X sodium chloride-sodium citrate (SSC)-0.1% sodium 
dodecyl sulfate (SDS) for 10 min at room temperature, followed by two 
or three consecutive 15- to 20.min washes in 0.1 X SSC-0.1% SDS at 
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65 C, and exposed to Kodak X-Omat film (Eastman Kodak, Roches- 
ter, NY) for l-5 days at -70 C. 
Ligand receptor cross-linking 
Cross-linking of [iZ51]hFSH to binding sites in transfected 293 cells 
and rat testicular homogenates was performed using disuccinimidyl 
suberate (Pierce, Rockford, IL), as previously described (34). Briefly, 6 X 
10h transfected 293 cells or homo 
B 
enate from 10 immature rat testes 
were incubated with 8 X lo5 cpm [ Z51]hFSH in the absence or presence 
of a lOOO-fold excess of unlabeled hormone at 22 C for 20 h in a total 
volume of 0.4 ml. After incubation, cells or homogenates were diluted 
with 1 ml wash solution (Dulbecco’s PBS containing 0.1% BSA, 5 mM 
EDTA, and 5 rnM N-ethylmaleimide), pelleted by centrifugation, washed, 
and recentrifuged. Pellets were then resuspended in 0.5 ml incubation 
buffer (D-PBS containing 10% dimethylsulfoxide), and disuccinimidyl 
suberate (freshly prepared in dimethylsulfoxide) was added to a final 
concentration of 1.5 mM. Cross-linking was carried out at 0 C for 30 
min, and the reaction was stopped by the addition of 1 ml termination 
buffer [50 rnM Tris-HCl (pH 7.5) and 100 mM NaCl]. The reaction tubes 
were centrifuged, and pellets were resuspended in 0.1 ml solubilization 
buffer [50 rnM Tris-HCl (pH 7.5) and 1% Triton X-100]. Solubilization 
was performed by incubation at 0 C for 60 min, with mixing of samples 
every 15 min. The samples were centrifuged for 5 min at 13,000 X g, 
and the resultant supernatants were resolved by SDS-polyacrylamide 
gel electrophoresis (SDS-PAGE), using 8.5% polyacrylamide gels. The 
gels were then subjected to autoradiography at -70 C for 2-14 days. 
Results 
Expression and binding kinetics of hFSH receptors in 
eukaryotic cells 
Cells derived from a human fetal kidney cell line (293) 
were transfected with the plasmid pCME-hFSHR. After a 
24-h incubation, cells were analyzed by radio&and receptor 
binding (Fig. 1). A dose-dependent increase in specifically 
bound [‘251]hFSH was detected in transfected cells incubated 
with increasing concentrations of labeled FSH, whereas no 
0.16 k-l.7 nM 
c 0.50 m 
0.26 
/ 0 0 30 Bound 00 20 (PM) 120 160 I”:k , , , , , / , , , 
0 10 20 30 40 50 60 70 60 90 
[‘261]-hFSH (rig/ml) 
FIG. 1. Binding of [iz51]hFSH to hFSH receptors expressed in euka- 
ryotic cells. 293 cells were transfected with the hFSH receptor plasmid 
pCME-hFSHR, and binding of radiolabeled hFSH was determined 24 
h later. Cells (2 x 105/tube x 0.4 ml) were incubated with increasing 
concentrations of [iZ51]hFSH in the absence or presence of a 1000-fold 
excess of unlabeled ligand. Levels of specifically bound [iZ51]hFSH are 
shown together with the derived Scatchard plot (inset; B/F, bound to 
free ratio). Data are the mean + SEM of triplicate determinations from 
a representative experiment. 
specific binding was observed in nontransfected cells (data 
not shown). Analysis of receptor binding indicated a Kd value 
Of 1.7 x 1o-9 M. 
To study the effects of incubation time and temperature 
on the kinetics of FSH receptor binding, transfected 293 cells 
were incubated with [‘251]hFSH at 4,22, or 37 C for increasing 
lengths of time, after which specific binding was determined 
(Fig. 2). A time-dependent increase in the levels of specific 
FSH binding was observed in cells incubated at 22 and 37 
C, whereas low levels of [‘251]hFSH binding were detected at 
4 C. Maximal FSH binding was highest in cells incubated at 
22 C, although the time required to reach maximal ligand 
binding was considerably longer in incubations conducted at 
22 us. 37 C (Fig. 2). 
Interaction of hFSH receptor with recombinant and pituitary/ 
urinary-derived human gonadotropin-s and TSH 
To test the binding specificity of the expressed hFSH 
receptor for human gonadotropins, transfected 293 cells were 
incubated with [‘251]hFSH in the absence or presence of 
increasing doses of unlabeled urinary-derived hCG, or hFSH, 
hLH, or hTSH of both pituitary and recombinant origin. 
Displacement of labeled FSH from its binding sites was 
expressed relative to the total amount of specifically bound 
[‘251]hFSH (Fig. 3). Both recombinant and pituitary FSH 
preparations competed with [‘251]hFSH for FSH receptors 
expressed in 293 cells (EDso: recombinant, 25 rig/ml; pitui- 
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FIG. 2. Effects of incubation time and temperature on rate and extent 
of [iZ51]hFSH binding to 293 cells. Transfected 293 cells (2 x 105/tube) 
expressing hFSH receptors were incubated with radiolabeled hFSH in 
the absence or presence of a 1000-fold excess of ligand at 4, 22, or 37 
C for increasing lengths of time, after which levels of specifically bound 
[iz51]hFSH were calculated (mean & SEM of triplicate determinations 
from a representative experiment). An enlarged figure for the first 4 h 
of incubation is presented in the inset. 
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FIG. 3. Interaction of recombinant (RC) and pituitary/urinary-derived 
human gonadotropins and TSH with hFSH receptors expressed in 
transfected 293 cells. Displacement of [“51]hFSH binding to hFSH 
receptors by hFSH, hLH, hCG, or hTSH was determined in radioligand 
receptor assays (mean + SEM of three replicate experiments). 
TSH were effective only at high doses. In contrast, negligible 
interaction of hCG or recombinant hLH or hTSH with the 
expressed FSH receptors was observed (Fig. 3). 
Ligand specificity of human vs. rat FSH receptors 
To assess the ligand specificity of the hFSH receptor, 293 
cells expressing human receptors were incubated with [125I] 
hFSH in the absence or presence of increasing doses of eCG 
(PMSG) or FSH from human, rat, ovine, and porcine origin. 
Displacement of [‘251]hFSH by unlabeled hormone in the 
human receptor was compared to that of testicular homoge- 
nates from 15-day-old rats (Fig. 4). hFSH and rFSH prepa- 
rations were effective in binding to the recombinant hFSH 
receptor (EDso: hFSH, 70 rig/ml; rFSH, 125 rig/ml), whereas 
only minimal interaction of oFSH, pFSH, or eCG with hFSH 
receptors was observed (Fig. 4A). In contrast, FSH from rat, 
human, and ovine origin as well as eCG effectively competed 
with radiolabeled FSH for binding sites in rat testicular 
homogenates (hFSH = rFSH > oFSH > eCG); however, 
pFSH was effective only at high doses (Fig. 4B). 
Gonadotropin stimulation of CAMP production and tPA 
promoter-luciferase reporter gene by transfected 293 cells 
expressing hFSH receptors 
The functional capacity of the recombinant hFSH receptor 
was tested based on gonadotropin stimulation of CAMP 
production by transfected 293 cells. Treatment of cells with 
human pituitary FSH caused a dose-dependent increase in 
CAMP formation (EDso, 10 rig/ml), with a maximal 13-fold 
increase observed in response to 100 rig/ml FSH (Fig. 5A). 
Human pituitary LH also increased CAMP production at 
doses of 100 (4-fold) and 1000 (6.6-fold) rig/ml, whereas 
neither hCG nor recombinant hLH altered CAMP levels 
compared to control values (Fig. 5A). 
Our earlier data demonstrated the stimulation of rat tPA 
rFSH 
IPSH 
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FIG. 4. Displacement of [‘251]hFSH binding to human and rat FSH 
receptors by human, rat, ovine, equine, and porcine gonadotropins. 
Transfected 293 cells expressing hFSH receptors (A) or rat testicular 
homogenates (B) were incubated with [Y]hFSH in the absence or 
presence of hFSH, rFSH, oFSH, or pFSH as well as eCG. Displacement 
curves are presented as a percentage of maximal binding at each dose 
of unlabeled hormone (mean + SEM of three replicate experiments). 
gene expression in ovarian granulosa cells (32). In granulosa 
cells transfected with a luciferase reporter gene driven by a 
CAMP-responsive region of the rat tPA gene promoter, treat- 
ment with FSH increases luciferase expression (29). Using 
this tPA-luciferase reporter plasmid, we evaluated the ability 
of human gonadotropins to induce luciferase activity in 293 
cells transfected with plasmids for both hFSH receptor and 
the reporter constructs. Treatment of cells with increasing 
doses of FSH, but not hCG, caused a dose-dependent in- 
crease in luciferase activity, with an estimated EDs0 of 8 ng/ 
ml and a maximal 2-fold increase at 100 rig/ml (Fig. 5B). 
These findings demonstrate a functional linkage of recom- 
binant hFSH receptors to the tPA gene. 
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FIG. 5. Gonadotropin stimulation of CAMP production (A) and luci- 
ferase activity (B) by 293 cells expressing hFSH receptors. A, Extra- 
cellular CAMP accumulation was measured after incubation of trans- 
fected 293 cells (2 x lO’/culture dish) for 2 h at 37 C with 0.25 mM 
MIX in the absence or presence of hFSH, hLH, or hCG. Data are the 
mean + SEM of six cultures from three replicate experiments (RC, 
recombinant). B. Dose-dependent stimulation of luciferase activity by 
hFSH, but nbt hCG, in 293 cells cotransfected with the hFSH receptor 
plasmid and a tPA promoter-luciferase r porter gene construct (note 
the break in the y-axis). Data are the mean + SEM of triplicate 
determinations from a representative xperiment. 
Northern blot analysis of FSH receptor mRNAs in human 
reproductive tissues 
To study the expression of hFSH receptor mRNA, RNA 
was extracted from human reproductive tissues and analyzed 
by Northern blot, using a radiolabeled cRNA probe corre- 
sponding to the extracellular region of cDNA from our cloned 
hFSH receptor (Fig. 6). Analysis of poly(A)-enriched mRNA 
prepared from human follicular phase ovary indicated the 
FIG. 6. Northern blot analysis of hFSH receptor mRNAs in human 
reproductive tissues. Poly(A)-enriched RNA samples prepared from 
human follicular phase ovary (FPO), Ll-day-old corpora lutea (CL), or 
Is-week-old placenta (PLC) (2 rg/lane) were resolved through dena- 
turing agarose gels, transferred to nitrocellulose filters, and hybridized 
to a 32P-labeled hFSH receptor cRNA probe. Filters were washed and 
exposed to photographic films for 5 days at -70 C. Migration distances 
of the 28s and 18s ribosomal RNAs of a Darallel total RNA samDle 
from human ovary are indicated. 
existence of three mRNA transcripts (7.0, 4.2, and 2.5 kb) 
that were not detected in an equivalent amount of mRNA 
prepared from corpus luteum (day 21 of the menstrual cycle) 
or placenta (week 19 of pregnancy; Fig. 6). 
Cross-linking of ~251]hFSH to FSH-binding sites in 
transfected cells and immature rat testes 
To estimate the molecular size of the recombinant hFSH 
receptor, [lz51]hFSH was cross-linked to FSH-binding sites in 
transfected 293 cells using disuccinimidyl suberate, followed 
by SDS-PAGE analysis (Fig. 7). A predominant autoradi- 
ographic band of protein, with an estimated molecular mass 
of 109 kilodaltons (kDa; 76 kDa for the binding protein after 
correction for mass attributed to the ligand) was detected in 
transfected cells expressing hFSH receptors, whereas a lOOO- 
fold excess of ligand completely blocked [‘251]hFSH binding 
(Fig. 7). A less abundant protein band of approximately 145 
kDa (112 kDa for the binding protein) was also present. 
These findings were comparable to those observed for FSH 
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FIG. 7. Cross-linking of hFSH- and rFSH-receptors to [‘251]hFSH. 
Radiolabeled hFSH was cross-linked to FSH receptors in transfected 
293 cells expressing hFSH receptors (HUMAN) or rat testicular ho- 
mogenates (RAT) using disuccinimidyl suberate. Proteins were sepa- 
rated through 8.5% polyacrylamide gels and analyzed by autoradiog- 
raphy (14 days at -70 C). The sizes of the proteins were estimated by 
comparison to migration distances of known protein mol wt standards. 
Symbols indicate the absence (-) or presence (+) of a lOOO-fold excess 
of ligand (Pergonal) during the binding incubation period before the 
cross-linking reaction. 
receptors found in testicular homogenates of immature rats 
under the same experimental conditions (Fig. 7). 
Discussion 
We report here the ligand specificity and biochemical 
properties of the recombinant hFSH receptor. Our data in- 
dicate that hFSH, but not LH or CG, competes with [lz51] 
hFSH for binding to the recombinant FSH receptor. In ad- 
dition, hFSH stimulates CAMP production in 293 cells ex- 
pressing the human receptor, whereas recombinant hLH and 
hCG are without effect. As a result of stimulation of endog- 
enous CAMP levels by FSH, a tPA promoter-driven luciferase 
reporter gene was also activated. Similar to the species- 
specific ligand binding recently reported for the hLH receptor 
(17), the recombinant hFSH receptor interacts with hFSH 
and rFSH, but only minimally with eCG or FSH of ovine 
and porcine origins. We also report here the first identifica- 
tion of FSH receptor mRNA in human ovaries as well as the 
determination of the molecular size of the recombinant hFSH 
receptor through ligand cross-linking analysis, 
Comparison of the present human testicular FSH receptor 
cDNA with an ovarian cDNA clone recently reported (24) 
indicated seven individual basepair substitutions throughout 
the receptor sequence, resulting in five amino acid changes. 
Although we are uncertain of the basis for the observed 
disparity between our and the reported clone, our FSH 
receptor cDNA could be expressed, whereas no expression 
data were reported for the ovarian clone. Additionally, four 
of the five variant amino acids are identical between our 
hFSH and the reported rFSH receptor sequence (13). The 
ability of 293 cells transfected with our cDNA to express 
high affinity FSH receptors coupled to the endogenous ad- 
enyl cyclase and a luciferase reporter gene indicates that our 
clone encodes for a functional protein. 
The availability of a cell line that expresses recombinant 
hFSH receptors has provided an unlimited source of the 
human receptor and enabled us to perform analysis of the 
ligand specificity of the human receptor. Radioligand recep- 
tor assays demonstrated that the hFSH receptor does not 
interact with hCG or recombinant hLH or hTSH at physio- 
logical or supraphysiological concentrations. However, 
highly purified human pituitary LH and TSH did cross-react 
with recombinant FSH receptors, suggesting that the pitui- 
tary hormone preparations contain minor FSH contamina- 
tion Furthermore, unlike the ability’ of rat testicular FSH 
receptors to recognize gonadotropin preparations from di- 
verse species (Ref. 35 and the present study), the human 
receptor interacted preferentially with human and rat FSH. 
These findings coupled with a similar species-specific ligand 
binding of hLH receptors (17) indicate significant evolution- 
ary changes in both human gonadotropin receptors. Alter- 
natively, we cannot rule out subtle differences in posttrans- 
lational processing of the receptor in 293 cells VS. gonadal 
cells that may influence its binding characteristics. However, 
the ligand specificity of hLH-binding sites expressed in 293 
cells (17) is identical to that of native LH receptors present 
in human corpus luteum (36), suggesting that the properties 
of these recombinant proteins are similar to those of endog- 
enous gonadal receptors. 
Saturation binding and Scatchard analysis demonstrated 
that the recombinant FSH-binding site has an estimated Kd 
of 1.7 nM, comparable to that reported for FSH receptors in 
human testes (37). In addition, the effects of incubation time 
and temperature on the rate and extent of [‘251]hFSH binding 
by recombinant hFSH receptors were similar to those re- 
ported for rat testicular FSH (35) and LH (38) receptors, 
Recombinant hFSH receptors occupied by gonadotropin are 
also capable of interacting with the endogenous G-proteins 
of the 293 cells to increase CAMP formation, thus providing 
a useful model to study FSH-activated signal transduction. 
Additionally, the use of a luciferase reporter gene driven by 
the CAMP-responsive promoter of the rat tPA gene (29) has 
indicated that transfected cells expressing hFSH receptors 
respond to FSH with increased luciferase activity. These 
findings provide evidence that FSH-induced signal transduc- 
tion in cells expressing recombinant hFSH receptors is cou- 
pled to the activation of genes that are regulated by gonad- 
otropins under physiological conditions within gonadal cells 
(32). However, the relatively small magnitude of the FSH 
response using the luciferase system (compared to CAMP) 
suggests a potential limitation of this assay in its present 
form. The reasons for this observation are unclear, but may 
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be related to the lack of gonadal cell-specific transcription 
factors in 293 cells that limit the activation of the luciferase 
reporter gene construct. Nonetheless, future modifications of 
the present cell model and the CAMP-driven luciferase gene 
reporter system should provide a useful and sensitive bioas- 
say for hFSH. 
The availability of hFSH receptor cDNA enabled us to 
study FSH receptor mRNA transcripts within human repro- 
ductive tissues. Northern blot analysis revealed the existence 
of several FSH receptor mRNAs within human follicular 
phase ovary, consistent with those reported for multiple FSH 
receptor mRNA transcripts in rat gonadal tissues (20,39,40). 
However, RNA prepared from human corpora lutea did not 
contain detectable levels of this message, suggesting that 
ovarian FSH receptor mRNA levels undergo up- and down- 
regulation during the human menstrual cycle in a manner 
similar to that reported for experimental animal models (20, 
41). 
Based on the deduced amino acid sequence of the hFSH 
receptor cDNA, the calculated molecular mass of the mature 
protein is approximately 75.6 kDa, consistent with the size 
estimation of recombinant FSH receptor based on ligand 
cross-linking and SDS-PAGE and comparable to that ob- 
served for FSH receptors in immature rat testes. Of interest 
was the finding of a less abundant 112-kDa FSH-binding 
site in both transfected 293 cells and rat testes, presumably 
resulting from posttranslational glycosylations of the protein. 
Alternatively, the smaller FSH-binding site may arise from 
proteolytic cleavage of the larger 112-kDa protein, as has 
been suggested by previous studies on hCG-binding sites in 
rat gonadal tissues (42). 
Previous studies using nonreducing PAGE followed by 
ligand blotting have estimated the size of the FSH receptor 
in bovine and rat testicular membranes to be approximately 
240 kDa (43, 44), possibly resulting from receptor aggrega- 
tion and dimer formation. Moreover, photoaffinity labeling 
of the pFSH receptor revealed the presence of a major cross- 
linked complex of 104 kDa, which could be reduced with 
dithiothrietol into two smaller complexes of 75 and 61 kDa 
(45). Although the reasons for the discrepancy between our 
and earlier findings are unclear, they may result from varying 
methodologies (e.g. ligand-receptor cross-linking US. ligand 
blotting) or species differences. Our data, however, suggest 
that binding of FSH does not require prior dimerization of 
its receptor on the plasma membrane, although it is possible 
that receptor aggregation may be important for receptor 
stability and/or signal transduction (46). 
Expression of the hFSH receptor provides unlimited ma- 
terial for future studies of clinical interest. Additionally, the 
ability to measure CAMP production and luciferase reporter 
gene activity in a cell line expressing hFSH receptors should 
allow the establishment of a sensitive bioassay for human 
gonadotropins and for screening new FSH agonists and 
antagonists. Because earlier reports have suggested the pres- 
ence of circulating antibodies against FSH receptor in patients 
with premature ovarian failure (47-49), the etiology of path- 
ophysiological conditions associated with gonadotropin re- 
ceptor dysfunction may also be more clearly elucidated. 
Note Added in Proof 
Amplification of human ovarian and testicular mRNA by reverse 
transciption polymerase chain reaction with oligonucleotide primers 
suecific for human FSH receptor cDNA seauences, followed bv direct 
I  1 I  , 
sequencing of resultant I’CR products after T7 gene 6 exonuclease 
treatment (50), indicated 100% sequence identity of this human FSH 
receptor cDNA with our clone obtained by cDNA library screening. 
Furthermore, independent cloning of human FSH receptor cDNA by R. 
Dijkema and R. de Leeuw (Organon, Oss, the Netherlands) also indi- 
cated 100% sequence identity with our cDNA clone (personal commu- 
nication). Accession no. M95489. 
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